-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lomond Therapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2022 to 2024.
- Lomond Therapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 5.18M shares, a 582% increase year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 5.18M shares, a 582% increase from 2023.
- Lomond Therapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 759K shares, a 84.8% decline from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)